Berita/Gilead Says 75.4% Of Livdelzi Recipients Achieve ALP Normalization At Week 52 Versus 16.1% PlaceboGilead Says 75.4% Of Livdelzi Recipients Achieve ALP Normalization At Week 52 Versus 16.1% PlaceboBaca artikel penuhDapatkan akses tanpa had kepada artikel dari Reuters dan semua sumber berita di TradingView.Teruskan membaca
